Overview of Monoclonal Antibodies and Small Molecules Targeting the Epidermal Growth Factor Receptor Pathway in Colorectal Cancer
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 5, S71-S80
- https://doi.org/10.3816/ccc.2005.s.010
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitorsAnnals of Oncology, 2005
- HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation Outcomes from the HER1/EGFR Inhibitor Rash Management ForumThe Oncologist, 2005
- A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor ActivityJournal of Biological Chemistry, 2005
- Structural basis for inhibition of the epidermal growth factor receptor by cetuximabPublished by Elsevier ,2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Integrin activationJournal of Cell Science, 2004
- EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain DimerizationPublished by Elsevier ,2003
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor αCell, 2002
- Epidermal Growth Factor Receptor in Vulvar Malignancies and Its Relationship to Metastasis and Patient SurvivalGynecologic Oncology, 1997